Variant report

Variant	nsv876738
Chromosome Location	chr3:46639048-46680063
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:636)
CpG islands
(count:427)
Chromatin interactive
region (count:29)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:636 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:46649302-46649337	HepG2	liver:	n/a	n/a
2	ATF1	chr3:46661623-46661869	K562	blood:	n/a	n/a
3	ATF2	chr3:46649045-46649544	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF2	chr3:46671272-46671937	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF2	chr3:46671292-46671865	H1-hESC	embryonic stem cell:	n/a	n/a
6	ATF3	chr3:46671409-46671780	K562	blood:	n/a	n/a
7	ATF3	chr3:46671400-46671857	H1-hESC	embryonic stem cell:	n/a	n/a
8	ATF3	chr3:46671570-46671752	GM12878	blood:	n/a	n/a
9	BACH1	chr3:46671292-46671750	H1-hESC	embryonic stem cell:	n/a	n/a
10	BHLHE40	chr3:46671448-46671810	GM12878	blood:	n/a	chr3:46671654-46671670
11	BHLHE40	chr3:46671422-46671839	K562	blood:	n/a	chr3:46671654-46671670
12	BHLHE40	chr3:46649279-46649547	K562	blood:	n/a	n/a
13	CBX3	chr3:46671216-46671805	K562	blood:	n/a	n/a
14	CCNT2	chr3:46671310-46671777	K562	blood:	n/a	n/a
15	CEBPB	chr3:46674348-46674548	HepG2	liver:	n/a	chr3:46674459-46674470
16	CEBPB	chr3:46649025-46649393	K562	blood:	n/a	chr3:46649219-46649232 chr3:46649219-46649232 chr3:46649220-46649231
17	CEBPB	chr3:46645620-46645975	HepG2	liver:	n/a	chr3:46645797-46645808
18	CEBPB	chr3:46649053-46649421	Hela-S3	cervix:	n/a	chr3:46649219-46649232 chr3:46649219-46649232 chr3:46649220-46649231
19	CEBPB	chr3:46650853-46651103	K562	blood:	n/a	chr3:46650974-46650985 chr3:46650973-46650986
20	CEBPB	chr3:46653797-46654232	ECC-1	luminal epithelium:	n/a	n/a
21	CEBPB	chr3:46649004-46649425	K562	blood:	n/a	chr3:46649219-46649232 chr3:46649219-46649232 chr3:46649220-46649231
22	CEBPB	chr3:46651566-46651908	K562	blood:	n/a	chr3:46651729-46651740
23	CEBPB	chr3:46645800-46645819	K562	blood:	n/a	n/a
24	CEBPB	chr3:46650783-46651144	Hela-S3	cervix:	n/a	chr3:46650974-46650985 chr3:46650973-46650986
25	CEBPB	chr3:46651655-46651840	Hela-S3	cervix:	n/a	chr3:46651729-46651740
26	CEBPB	chr3:46650828-46651092	HepG2	liver:	n/a	chr3:46650974-46650985 chr3:46650973-46650986
27	CEBPB	chr3:46674290-46674629	IMR90	lung:	n/a	chr3:46674459-46674470
28	CEBPB	chr3:46645681-46645885	HepG2	liver:	n/a	chr3:46645797-46645808
29	CEBPB	chr3:46649093-46649412	HepG2	liver:	n/a	chr3:46649219-46649232 chr3:46649219-46649232 chr3:46649220-46649231
30	CEBPB	chr3:46674301-46674649	HepG2	liver:	n/a	chr3:46674459-46674470
31	CEBPB	chr3:46674311-46674640	MCF-7	breast:	n/a	chr3:46674459-46674470
32	CEBPB	chr3:46651613-46651911	HepG2	liver:	n/a	chr3:46651729-46651740
33	CEBPB	chr3:46650819-46651132	IMR90	lung:	n/a	chr3:46650974-46650985 chr3:46650973-46650986
34	CEBPB	chr3:46670495-46670689	HepG2	liver:	n/a	chr3:46670542-46670553
35	CEBPB	chr3:46649139-46649398	K562	blood:	n/a	chr3:46649219-46649232 chr3:46649219-46649232 chr3:46649220-46649231
36	CEBPB	chr3:46651546-46651888	IMR90	lung:	n/a	chr3:46651729-46651740
37	CEBPB	chr3:46649051-46649482	H1-hESC	embryonic stem cell:	n/a	chr3:46649219-46649232 chr3:46649219-46649232 chr3:46649220-46649231
38	CEBPB	chr3:46653729-46654347	ECC-1	luminal epithelium:	n/a	n/a
39	CEBPB	chr3:46674442-46674584	H1-hESC	embryonic stem cell:	n/a	chr3:46674459-46674470
40	CEBPB	chr3:46674341-46674550	K562	blood:	n/a	chr3:46674459-46674470
41	CEBPB	chr3:46674353-46674610	Hela-S3	cervix:	n/a	chr3:46674459-46674470
42	CHD1	chr3:46641007-46641165	H1-hESC	embryonic stem cell:	n/a	n/a
43	CHD2	chr3:46650776-46650811	HepG2	liver:	n/a	n/a
44	CHD2	chr3:46641425-46641543	H1-hESC	embryonic stem cell:	n/a	n/a
45	CHD2	chr3:46671306-46671702	GM12878	blood:	n/a	n/a
46	CHD2	chr3:46650817-46651029	Hela-S3	cervix:	n/a	n/a
47	CHD2	chr3:46671286-46671727	H1-hESC	embryonic stem cell:	n/a	n/a
48	CREB1	chr3:46671366-46671743	A549	lung:	n/a	n/a
49	CREB1	chr3:46671224-46671868	H1-hESC	embryonic stem cell:	n/a	n/a
50	CREB1	chr3:46671206-46671909	H1-hESC	embryonic stem cell:	n/a	n/a

(count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:46640523-46640573	LNCaP	prostate:	n/a
2	chr3:46672436-46672486	Hela-S3	cervix:	n/a
3	chr3:46651373-46651423	NHDF-neo	bronchial:	n/a
4	chr3:46671563-46671613	HEK293	kidney:	embryo
5	chr3:46661640-46661690	ProgFib	skin:	n/a
6	chr3:46671334-46671384	A549	lung:	n/a
7	chr3:46640523-46640573	ProgFib	skin:	n/a
8	chr3:46671334-46671384	LNCaP	prostate:	n/a
9	chr3:46651373-46651423	Hepatocyte	liver:	n/a
10	chr3:46671563-46671613	HCPEpiC	choroid plexus:	n/a
11	chr3:46672436-46672486	MCF-7	breast:	n/a
12	chr3:46671334-46671384	ProgFib	skin:	n/a
13	chr3:46669290-46669340	GM06990	blood:	n/a
14	chr3:46671563-46671613	ECC-1	luminal epithelium:	n/a
15	chr3:46661640-46661690	BE2_C	brain:	n/a
16	chr3:46669290-46669340	U87	brain:	n/a
17	chr3:46669290-46669340	HCT-116	colon:	n/a
18	chr3:46671334-46671384	PrEC	prostate:	n/a
19	chr3:46672436-46672486	NT2-D1	testis:	n/a
20	chr3:46661640-46661690	HCM	heart:	n/a
21	chr3:46669290-46669340	ECC-1	luminal epithelium:	n/a
22	chr3:46651373-46651423	HIPEpiC	eye:	n/a
23	chr3:46671563-46671613	NT2-D1	testis:	n/a
24	chr3:46671563-46671613	HPAEpiC	pulmonary alveolar:	n/a
25	chr3:46661640-46661690	T-47D	breast:	n/a
26	chr3:46651373-46651423	SKMC	muscle:	n/a
27	chr3:46671563-46671613	NH-A	brain:	n/a
28	chr3:46671563-46671613	Jurkat	blood:	n/a
29	chr3:46671334-46671384	NH-A	brain:	n/a
30	chr3:46661640-46661690	HEEpiC	esophagus:	n/a
31	chr3:46661640-46661690	H1-hESC	embryonic stem cell:	embryo
32	chr3:46671334-46671384	CMK	blood:	n/a
33	chr3:46671334-46671384	HPAEpiC	pulmonary alveolar:	n/a
34	chr3:46672436-46672486	PrEC	prostate:	n/a
35	chr3:46661640-46661690	HEK293	kidney:	embryo
36	chr3:46669290-46669340	BE2_C	brain:	n/a
37	chr3:46669290-46669340	HMEC	breast:	n/a
38	chr3:46672436-46672486	GM12891	blood:	n/a
39	chr3:46671334-46671384	HUVEC	blood vessel:	n/a
40	chr3:46671563-46671613	Hela-S3	cervix:	n/a
41	chr3:46672436-46672486	GM12878	blood:	n/a
42	chr3:46671334-46671384	U87	brain:	n/a
43	chr3:46671334-46671384	BJ	skin:	n/a
44	chr3:46661640-46661690	NT2-D1	testis:	n/a
45	chr3:46671563-46671613	HUVEC	blood vessel:	n/a
46	chr3:46651373-46651423	HMEC	breast:	n/a
47	chr3:46651373-46651423	HRE	kidney:	n/a
48	chr3:46669290-46669340	GM12891	blood:	n/a
49	chr3:46671334-46671384	HepG2	liver:	n/a
50	chr3:46669290-46669340	SAEC	small airway:	n/a

(count:29 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:46529871..46530872-chr3:46670590..46672462,23	K562	blood:
2	chr3:46634620..46635722-chr3:46671175..46672074,5	MCF-7	breast:
3	chr3:46670110..46673240-chr3:46702336..46706371,4	MCF-7	breast:
4	chr3:46551542..46553996-chr3:46670081..46671656,2	K562	blood:
5	chr3:46679942..46681539-chr3:46683800..46686351,2	K562	blood:
6	chr3:46679929..46681970-chr3:46683200..46686358,3	MCF-7	breast:
7	chr3:46650273..46651172-chr3:46707945..46708857,7	MCF-7	breast:
8	chr3:46671186..46671992-chr3:46701370..46702228,2	MCF-7	breast:
9	chr3:46652193..46653784-chr3:46656998..46659238,2	K562	blood:
10	chr3:46599516..46600466-chr3:46671185..46672080,3	MCF-7	breast:
11	chr3:46436315..46436954-chr3:46671328..46672082,2	K562	blood:
12	chr3:46652193..46653784-chr3:46656998..46659238,2	K562	blood:
13	chr3:46658701..46661042-chr3:46905477..46908148,2	MCF-7	breast:
14	chr3:46676467..46678171-chr3:46680903..46682771,2	K562	blood:
15	chr3:46617160..46620139-chr3:46640336..46642937,2	MCF-7	breast:
16	chr3:46675056..46675850-chr3:46708207..46708731,2	MCF-7	breast:
17	chr3:46529884..46530839-chr3:46671105..46672532,19	MCF-7	breast:
18	chr3:46503615..46504280-chr3:46671186..46672162,2	MCF-7	breast:
19	chr3:46670811..46674020-chr3:46675061..46678300,4	K562	blood:
20	chr3:46529878..46530429-chr3:46671116..46672037,3	MCF-7	breast:
21	chr3:46634709..46635296-chr3:46671423..46672075,2	MCF-7	breast:
22	chr3:46503439..46504291-chr3:46671319..46672034,3	K562	blood:
23	chr3:46650273..46651172-chr3:46707945..46708857,6	MCF-7	breast:
24	chr3:46650761..46651345-chr3:46671138..46672058,2	MCF-7	breast:
25	chr3:46671153..46671844-chr3:46736764..46737267,2	MCF-7	breast:
26	chr3:46653817..46656783-chr3:46662139..46665039,2	K562	blood:
27	chr3:46670790..46673610-chr3:46733778..46736108,3	MCF-7	breast:
28	chr3:46650761..46651345-chr3:46671138..46672058,2	MCF-7	breast:
29	chr3:46670811..46674020-chr3:46675061..46678300,4	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TMIE-1	chr3:46667272-46667698	NONHSAT089452
2	lnc-RTP3-2	chr3:46658673-46658716	NONHSAT089450

No data

Variant related genes	Relation type
ENSG00000256354	TF binding region
TDGF1	TF binding region
ENSG00000256354	CpG island
TDGF1	CpG island
ENSG00000241186	chromatin interactions
ENSG00000178038	chromatin interactions

Extended variants
information (count: 1647 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:1647 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1520494	chr3:46639048-46639049	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs549902810	chr3:46639051-46639052	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs562327060	chr3:46639072-46639073	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs532985668	chr3:46639121-46639122	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs143922499	chr3:46639139-46639140	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs566612848	chr3:46639141-46639142	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs181177334	chr3:46639185-46639186	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs548656090	chr3:46639190-46639191	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs567318628	chr3:46639230-46639231	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs377405593	chr3:46639337-46639338	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs536338182	chr3:46639359-46639360	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs142801942	chr3:46639394-46639395	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs147239361	chr3:46639415-46639416	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs186362825	chr3:46639425-46639426	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs571851156	chr3:46639460-46639461	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs538832372	chr3:46639485-46639486	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs187992703	chr3:46639513-46639514	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs56008703	chr3:46639520-46639521	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs181004680	chr3:46639564-46639565	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs117246730	chr3:46639588-46639589	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs12636685	chr3:46639591-46639592	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs554655072	chr3:46639602-46639603	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs111986830	chr3:46639639-46639640	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs535193210	chr3:46639661-46639662	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs543489351	chr3:46639663-46639664	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs57150900	chr3:46639695-46639696	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs548588996	chr3:46639737-46639738	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs568408451	chr3:46639757-46639758	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs565010102	chr3:46639766-46639767	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs140758873	chr3:46639776-46639777	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs186251061	chr3:46639781-46639782	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs553647643	chr3:46639819-46639820	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs149849159	chr3:46639854-46639855	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs527589879	chr3:46639864-46639865	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs549300780	chr3:46639866-46639867	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs191007871	chr3:46639893-46639894	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs531365379	chr3:46639897-46639898	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs11709309	chr3:46639994-46639995	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs571333501	chr3:46640018-46640019	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs548831654	chr3:46640035-46640036	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs113749139	chr3:46640049-46640050	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs139222542	chr3:46640050-46640051	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs117539488	chr3:46640052-46640053	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs80331683	chr3:46640060-46640061	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs200959164	chr3:46640061-46640062	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs538738855	chr3:46640112-46640113	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs112204861	chr3:46640184-46640185	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs539032357	chr3:46640198-46640199	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs186846890	chr3:46640234-46640235	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs554067162	chr3:46640281-46640282	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
Glioblastoma multiforme	21080181	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17133270	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Melanoma	20688739	CNVD
Acute myeloid leukemia	21251322	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Kartagener syndrome	16639409	CNVD
Biliary cancer	19435499	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Breast cancer	21509527	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	16397240	CNVD
Breast cancer	22032731	CNVD
Non-small cell lung cancer	20864512	CNVD
Colorectal cancer	16912164	CNVD
Non-small cell lung cancer	19010865	CNVD
Colorectal cancer	16272173	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Acute myeloid leukemia	17268525	CNVD
Salivary gland tumor	18059337	CNVD
Gastric cancer	16891809	CNVD
Night blindness	17160897	CNVD
Cancer	17160897	CNVD
Breast cancer	20409316	CNVD
Lung cancer	17297452	CNVD
Multiple myeloma	16616336	CNVD
Effusion lymphoma	18079361	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Neuroblastoma	20406844	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Urothelial cell carcinoma	18451213	CNVD
Neuroblastoma	17327916	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Melanoma	17363583	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Adrenocortical carcinoma	18281524	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:723 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:46628800-46651000	Weak transcription	Right Atrium	heart
2	chr3:46634800-46650800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
3	chr3:46635000-46640200	Weak transcription	H9 Cell Line	embryonic stem cell
4	chr3:46635000-46641400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr3:46635600-46640200	Weak transcription	HUES64 Cell Line	embryonic stem cell
6	chr3:46636000-46639600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr3:46637400-46640200	Weak transcription	HUES6 Cell Line	embryonic stem cell
8	chr3:46637600-46640200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
9	chr3:46637800-46640200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
10	chr3:46637800-46640400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
11	chr3:46637800-46640400	Weak transcription	H1 Cell Line	embryonic stem cell
12	chr3:46638600-46644800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
13	chr3:46639000-46640400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
14	chr3:46639600-46640600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
15	chr3:46640200-46640400	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
16	chr3:46640200-46640400	Enhancers	iPS-20b Cell Line	embryonic stem cell
17	chr3:46640200-46641800	Enhancers	H9 Cell Line	embryonic stem cell
18	chr3:46640200-46641800	Enhancers	HUES64 Cell Line	embryonic stem cell
19	chr3:46640200-46641800	Enhancers	iPS-15b Cell Line	embryonic stem cell
20	chr3:46640200-46641800	Enhancers	iPS-18 Cell Line	embryonic stem cell
21	chr3:46640200-46641800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
22	chr3:46640200-46642000	Enhancers	HUES6 Cell Line	embryonic stem cell
23	chr3:46640200-46642000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
24	chr3:46640200-46642400	Enhancers	ES-I3 Cell Line	embryonic stem cell
25	chr3:46640400-46641000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
26	chr3:46640400-46641200	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
27	chr3:46640400-46641800	Enhancers	HUES48 Cell Line	embryonic stem cell
28	chr3:46640400-46642000	Enhancers	H1 Cell Line	embryonic stem cell
29	chr3:46640600-46644400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
30	chr3:46641000-46641400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
31	chr3:46641200-46641400	Enhancers	iPS-20b Cell Line	embryonic stem cell
32	chr3:46641400-46641600	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
33	chr3:46641400-46641800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr3:46641400-46642000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
35	chr3:46641600-46641800	Enhancers	iPS-20b Cell Line	embryonic stem cell
36	chr3:46641800-46644600	Weak transcription	HUES48 Cell Line	embryonic stem cell
37	chr3:46641800-46644600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
38	chr3:46641800-46644600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
39	chr3:46641800-46644800	Weak transcription	H9 Cell Line	embryonic stem cell
40	chr3:46641800-46644800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
41	chr3:46641800-46645000	Weak transcription	HUES64 Cell Line	embryonic stem cell
42	chr3:46642000-46644800	Weak transcription	H1 Cell Line	embryonic stem cell
43	chr3:46642000-46644800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
44	chr3:46642000-46645000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
45	chr3:46642000-46645000	Weak transcription	HUES6 Cell Line	embryonic stem cell
46	chr3:46642400-46644800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
47	chr3:46644400-46645000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
48	chr3:46644400-46645200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
49	chr3:46644600-46645400	Enhancers	Fetal Heart	heart
50	chr3:46644600-46646600	Enhancers	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links